INDIANAPOLIS, Indiana, June 6 (TNSjou) -- The American Diabetes Association issued the following news release: * * * Data Shows Potential Breakthrough Treatment Option for Glucose Management in Adolescents with Uncontrolled Diabetes * * * Findings from an international study show a once-weekly injection of dulaglutide was superior in improving glycemic control in youth with type 2 diabetes compared to placebo. The trial was presented at the 82nd Scientific Sessions of the American Diabetes A  more

BOSTON, June 6 (TNSjou) -- The Dana-Farber Cancer Institute issued the following news release: Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option. The study, being presented today at the Annual Meeting of the American Society of Clinical Oncology  more

BALTIMORE, Maryland, June 6 (TNSjou) -- Johns Hopkins Medicine issued the following news release: * * * Helps clarify the benefit of chemotherapy in stage II cancers * * * A new research study showed that circulating tumor DNA (ctDNA) -- genetic material shed from tumors into the bloodstream -- can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of treatment. The multi-institutional, internation  more